12
Participants
Start Date
September 30, 2009
Primary Completion Date
September 30, 2011
Study Completion Date
October 31, 2011
fludarabine
fludarabine 40mg/m2/day orally on Days 1 to 5 of every 35-day cycle
rituximab
rituximab 375mg/m2 on Day 1 of every 35-day cycle
VELCADE
1.6 mg/m2 intravenously (IV) on Days 1, 8, 15, and 22 of every 35-day cycle
Kantonsspital St.Gallen Department of Oncology/Hematology, Sankt Gallen
Vivantes Klinikum am Urban, Berlin, BE
Hospital Puerta del Mar, Secretaría de Hematología, 1ª planta, Cadiz
Laiko Hospital - 1st Dept. of Propaedeutic Internal Medicine, Athens
Haemek Medical Center - Hematology Department, Afula
Hospital General Universitario Morales Meseguer, Secretaría de Hematología, 1ª planta, Murcia
CHU Caremeau, Nîmes
Rambam Med.Center - Hematology Institute, Haifa
Institut Bergonie, Bordeaux
Hospital Clinico Universitario Salamanca, Servicio de Hematología, 4º Planta, Salamanca
Rabin Medical Center - Hematology Institute, Petah Tikva
Sheba MC - Hematology Institute, Ramat Gan
Universitaetsklinikum Mainz, Mainz
CHU Hotel Dieu, Clermont-Ferrand
University Hospital of Heraklion- Department of Hematology, Heraklion- Crete
Centre Victor Hugo, Le Mans
Hoptial Saint Louis, Paris Cedex 10, 75
Hopital Cochin, Paris, 75, Cedex 14
Klinikum der Stadt Villinger-Schwenningen, Villingen-Schwenningen
CHU d'Amiens, Amiens
Hadassah University Hospital - Hematology Department, Jerusalem
Klinikum Bamberg, fachbereich 3, Bamberg
Charite, group Benjamin Franklin, Berlin
Hospital Spandau, Berlin
Universitaetsklinikum Frankfurt, Frankfurt
Universitatsklinikum Gottingen, zentrum Innere medicin, Göttingen
Evangelisches Krankenhaus Hamm, Hamm
Klinikum Idar-Oberstein GmbH, Idar-Oberstein
Universitaetsklinikum Jena, Jena
Universitaetsklinikum Leipzig, Leipzig
Robert Bosch Krankenhaus, Stuttgart
Mutterhaus der Borromaeerinnen, Trier
Universitatsklinikum Ulm, Ulm
Policlinico di Bari, Bari
Istituto Di Ematologia E Oncologia Medica - L.A. Seragnoli - Policlinico S.Orsola Malpighi, Bologna
Clinica di Ematologia DIMI - A.O. Ospedale S. Martino, Genova
Ospedale Niguarda Ca' Granda, Milan
Azienda Ospedaliera Antonio Cardarelli, Napoli
Ospedale Policlinico San Matteo Irccs, Pavia
A.O.Univ.Pisana-Osp. Santa Chiara, Pisa
Azienda Ospedaliera Santa Maria di Terni, Terni
Divisione di Ematologia Ospedale San Bortolo - Hematology, Vicenza
Università La Sapienza, Dipartimento di Biotecnologie Cellulari ed Ematologia, Via Benevento, 6, Roma
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
INDUSTRY
Millennium Pharmaceuticals, Inc.
INDUSTRY